Industry Overview - The prevalence of short stature in Chinese children is approximately 3%, with around 8 million children aged 3-15 requiring intervention, increasing by 160,000 annually [1] - The market for children's nutrition and height enhancement is projected to exceed 200 billion yuan by 2025, with the height management product market exceeding 10 billion yuan, but there is a 60% gap in specialized products [2] - The growth retardation rate among rural children under 6 years old has reached 5.8%, leading to significant psychological issues for 90% of affected children [1][2] Company Insights - The research team led by Professor Zhang Heping has developed a patented probiotic strain, UP-1, which activates the GH-IGF-1 growth axis, promoting bone health and growth [4][8] - The product "NICE GROW" probiotic oil drops contains over 500 billion effective live bacteria, with UP-1 accounting for at least 400 billion, making it affordable for Chinese families [8][11] - The company, Ketaobiotech, is recognized as a leading supplier in the probiotic industry, providing products to national sports teams and collaborating with numerous enterprises and research institutions [11][13]